References
- Tomasz A. The role of autolysin in cell death. Ann NY Acad Sci 1974; 235: 439–447
- Sabbath L D, Wheeler N, Laverdiere M, Biazevic D, Wilkinson B J. A new type of penicillin resistance of Staphylococcus aureus. Lancet 1977; 1: 443–447
- Goldman P L, Petersdorf R G. Significance of methicillin tolerance in experimental staphylococcal endocarditis. Antimicrob Agents Chemother 1979; 15: 802–806
- Rajashekaraiah K R, Rice T, Ras V S, Marsh D, Ramakrishna B, Kallich C A. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med 1980; 93: 796–801
- Goessens W HF, Fontijne P, v Raffe M, Michel M. Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains. Antimicrob Agents Chemother 1984; 25: 575–577
- Goessens W HF, Fontijne P, Michel M F. Factors influencing detection of tolerance in Staphylococcus aureus. Antimicrob Agents Chemother 1982; 22: 364–368
- Armitage P. Statistical methods in medical research. Blackwell, Oxford 1971
- Mayhall C G, Medoff G, Marr J J. Variations in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin and gentamycin. Antimicrob Agents Chemother 1976; 10: 707–712
- Best G K, Best N H, Koval A V. Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrob Agents Chemother 1974; 6: 825–830
- Hoogeterp J J, Mattie H, Krul A M, van Furth R. Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection. Antimicrob Agents Chemother 1987; 31: 930–934
- Goessens W HF, Fontijne P, Michel M F. Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice. Antimicrob Agents Chemother 1984; 26: 829–832
- Sheiner L B, Stanski D F, Vozeh S, Miller R D, Houn J. Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358–371
- Holford N HG, Sheiner L B. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6: 429–453